Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 1/20 | 0.40 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.40 |
| ▸ | PPARA | Q07869 | 11/20 | 0.40 |
| ▸ | PPARG | P37231 | 7/20 | 0.38 |
| ▸ | PPARD | Q03181 | 2/20 | 0.38 |
| ▸ | MMP8 | P22894 | 1/20 | 0.38 |
| ▸ | PTPRF | P10586 | 1/20 | 0.37 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.37 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.37 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5379702 | 0.87 | ESR1 (0.45) | PPARAPPARGSMN1; SMN2PTGS2 | |
| SCHEMBL5379694 | 0.87 | ESR1 (0.45) | PPARAPPARGSMN1; SMN2PTGS2 | |
| SCHEMBL6724780 | 0.87 | PPARA (0.42) | CYP4F2CYP4A11PPARAPPARGPPARD | |
| Hydrochloric Acid SCHEMBL6724404 | 0.84 | PPARA (0.39) | PPARAPPARGPPARDMMP8CPB2 | |
| SCHEMBL6731797 | 0.84 | CYP4F2 (0.51) | CYP4F2CYP4A11PPARAPPARGPPARD | |
| SCHEMBL4333358 | 0.81 | CYP4F2 (0.41) | CYP4F2CYP4A11PPARAPPARGPPARD | |
| SCHEMBL6723558 | 0.80 | ALDH1A1 (0.37) | CYP4F2CYP4A11PPARAPPARGMMP8 | |
| SCHEMBL5104386 | 0.78 | ESR1 (0.51) | PPARAPPARGPPARDSMN1; SMN2PTGS2 | |
| SCHEMBL5377710 | 0.78 | PPARA (0.63) | PPARAPPARGPPARD | |
| SCHEMBL6513434 | 0.77 | PPARA (0.52) | PPARAPPARGPPARDMMP8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040102634-A1 | Carboxylic acid derivative and salt thereof | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2004-05-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040102634-A1 | Carboxylic acid derivative and salt thereof | GPR119, IRS1, SLC5A1 | CYP4F2 792/4885CYP4A11 188/4885PPARA 339/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.